Furthermore, COL6A6 was reported to inhibit the PI3K-Akt pathway; Long et al. found that COL6A6 suppressed the growth and metastasis of pituitary adenocarcinoma by blocking the PI3K-Akt pathway (11). This evidence concerns the gene COL6A6 and pituitary adenocarcinoma.